TG-1601 is a Novel BET Inhibitor with Strong Binding Affinity and Long-lasting Effect in Pre-clinical Models

Drug Category : Array
Conference Category : Array
Lead Author : Normant, E et al
Published Date : 18/04/2018
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/Final-AACR-2018-BET-TG-1601.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top